Classes
Publications
- ANCA associated vasculitis anti PR 3 amntibodies is genetically distinct from anti-MPO antibody -relatid vase. Commentary on:NEJM 367,2012,214-2232012 | First Faculty of Medicine
- KDIGO guedlines for the diagnosis and treatment glomerulonephritis, What´s new? Commentary on:KI 2,212,139-2742012 | First Faculty of Medicine
- Angiopoetin - like protein 4 may be the long searched factor including proteinuria in nephrotic syndrome in minimal change disease. Commentary on: Nat. Med 17,2011,117-1222011 | First Faculty of Medicine
- What is new in the pathogenesis diagnostics and treatment of diabetic nephropathy. Commentary on: Mayo Clin Proc 86,2011,444-4562011 | First Faculty of Medicine
- Is the activation of EGF receptor the main mechanism of glomerular damage in rapidly progrsive glomerulonephritis?Commentary on: Nat Med 20112011 | First Faculty of Medicine
- Andothelin antagonist Avosentan in patients with diabetic nepropúathy dramatically decuase proteinuria but at the expense of fluid retention. Commentary on: JASN 21,2010,527-5352010 | First Faculty of Medicine
- Is terminal renal failure and death predictable in patients with advanced chronic kidney disease?Commebtary on:AJKD 56,2010,1082-942010 | First Faculty of Medicine
- The top ten things nephrologists wish every primary care physician knew. Commentary on: Mayo Clin Proc 84,2009,180-1862009 | First Faculty of Medicine
- Treatment of refractory ANCA-associated vasculitis with rituximab. Commentary on: Arthritis and Reheumatism 60,2009,s.2156-21682009 | First Faculty of Medicine
- Treatment with statins doesn´t lower the cardiovascular morbidity and mortality - results of AURORA study. Commentary on: NEJM 360,2009,1395-14072009 | First Faculty of Medicine
Loading network view...